Redwood City, CA, United States of America

Adam Silverman

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adam Silverman

Introduction

Adam Silverman is a prominent inventor based in Redwood City, CA. He has made significant contributions to the field of biomedical research, particularly in the development of polypeptides that target specific receptors involved in cancer treatment. With a total of 5 patents to his name, Silverman continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents are innovative polypeptides that target vascular endothelial growth factor receptor-2 and αvβ3 integrin. These polypeptides comprise variant vascular endothelial growth factor sequences, which are instrumental in cancer imaging, diagnosis, monitoring, and treatment. Additionally, they are useful in addressing diseases characterized by excessive neovascularization, showcasing Silverman's commitment to advancing medical science.

Career Highlights

Adam Silverman is affiliated with Leland Stanford Junior University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer therapies and diagnostics. Silverman's dedication to innovation is evident in his ongoing research and development efforts.

Collaborations

Some of his notable coworkers include Jennifer R. Cochran and Douglas Scott Jones. Their collaborative efforts contribute to the advancement of research in the biomedical sector, further enhancing the impact of their collective work.

Conclusion

Adam Silverman exemplifies the spirit of innovation in the field of biomedical research. His contributions through patents and collaborations are paving the way for advancements in cancer treatment and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…